The competition is coming on fast as you point out. It has greatly devalued combo, IMO. BP would have made a play for combo 2 years ago if they didn't know the other products were coming on, so now we really need to get mono rolling. I believe this new idea of extending the half life on our product is a move to address the competition. Still, it looks like others are sprinting to get theirs to market while we are off chasing NASH, GvHD, Prep, and the common cold.
News 
Market Data 
Discover 
AI
